Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Molecular Genetics, |
RCV002225149 | SCV002503620 | uncertain significance | Autosomal recessive Alport syndrome | 2023-03-30 | criteria provided, single submitter | clinical testing | This sequence change is predicted to replace proline with arginine at codon 911 of the COL4A4 protein, p.(Pro911Arg). The proline residue is moderately conserved (100 vertebrates, UCSC), and is located at the Y position in the G-X-Y collagen triple helix repeat in one of the intermediate collagenous domains. There is a large physicochemical difference between proline and arginine. The variant is present in a large population cohort at a frequency of 0.002%, consistent with recessive disease (rs764465049, 5/249,194 alleles, 0 homozygotes in gnomAD v2.1.1). It has not been previously reported in the relevant medical literature or databases. The variant has been identified in a suspected Alport syndrome case with a likely pathogenic COL4A4 variant (p.Ile29_Leu30del; Royal Melbourne Hospital). Multiple lines of computational evidence predict a deleterious effect for the missense substitution (5/6 algorithms). Based on the classification scheme RMH ACMG Guidelines v1.1.1, this variant is classified as a VARIANT of UNCERTAIN SIGNIFICANCE. Following criteria are met: PM2, PM3_Supporting, PP3. |
Labcorp Genetics |
RCV003089195 | SCV003470518 | likely benign | not provided | 2023-12-18 | criteria provided, single submitter | clinical testing |